Results 91 to 100 of about 11,119 (184)

Hypotension and bradycardia following varenicline overdose [Abstract]

, 2009
Objective: To report a case of symptomatic varenicline overdose in an adult. Case report: Varenicline is a new drug for smoking cessation. It is both a partial agonist and antagonist to the nicotine receptor.
Jones, S. S. D., Thompson, John Paul, Wood, K. L.   +2 more
core   +1 more source

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial

, 2018
Christine L Baker,1 Guilhem Pietri2 1Pfizer Inc., New York, NY, USA; 2Data Pyxis Ltd., St Albans, UK Background: The cost-effectiveness of varenicline has been demonstrated in the US health care setting using the Benefits of Smoking Cessation on Outcomes
Baker CL, Pietri G
core  

A preliminary benefit-risk assessment of varenicline in smoking cessation.

, 2009
Varenicline is a recently developed medication for smoking cessation, which has been available on prescription since 2006. It is a selective nicotinic acetylcholine receptor partial agonist, and is designed to reduce withdrawal symptoms and to lessen the
Lancaster, Timothy, Cahill, K, Stead, Lindsay, Lindsay Stead, Kate Cahill, Tim Lancaster   +5 more
core   +1 more source

Use of low-dose varenicline in hospitalized smokers: A case series low-dose varenicline in hospitalized smokers

SAGE Open Medical Case Reports
Nicotine replacement therapy is the primary medication used to treat tobacco dependence in hospitalized patients. Recent evidence shows that varenicline is more effective than nicotine replacement, but varenicline side effects limit its use in the ...
Rachael L. Joyner, Remi E. Phillips, Farid A. Manshaii, James M. Davis   +3 more
doaj   +1 more source

Le sevrage tabagique: une nouvelle molécule orale, la varenicline (Champix).

, 2007
Varenicline orally administered nicotine acetylcholine receptor partial agonist is approved by the US FDA and the MEA for use as an aid to smoking cessation therapy.
Perez Bogerd, Silvia, Sternon, Jacques
core  

Effect of varenicline on aspects of inhibitory control in smokers

, 2014
RATIONALE: Varenicline, a partial agonist at a4ß2 nicotinic receptors (nAChRs) aids smoking cessation by reducing craving. Successful quitting may be associated with greater inhibitory control but the effectiveness of varenicline in this regard is ...
A J Austin (16221413), A Jackson (9440984), Jennifer Rusted (4460485), Dora Duka (4460590)   +3 more
core  

Cardiovascular disease and varenicline (Champix) [PDF]

, 2013
Whilst findings were not uniform, based on the findings of these reviews, the risk of cardiovascular events associated with the use of varenicline is judged to be minimal and clinically insignificant.
Shahab, L
core  

Utilization of varenicline among Kansas Medicaid enrollees.

PLoS ONE
BackgroundSmoking prevalence among Medicaid beneficiaries is twice that of privately insured adults, yet effective smoking cessation treatments remain underutilized.
Nathalia M Machado, Aaron J Katz, Kimber P Richter, Edward F Ellerbeck   +3 more
doaj   +1 more source

Varenicline effects on cocaine self-administration and reinstatement behavior.

, 2010
International audienceThis study tested the effects of the nicotine addiction treatment varenicline on cocaine self administration (SA) and reinstatement.
Guillem, Karine, Peoples, L.L.
core   +1 more source

Impact of preoperative varenicline on postoperative outcomes in cardiac surgery: comparison with nicotine replacement therapy and active smoking

The Cardiothoracic Surgeon
Background Nicotine dependence increases the risk of adverse outcomes after cardiac surgery, but there are no current established studies directly comparing different smoking cessation medications’ effect on postoperative outcomes.
Jason H. Yan, Vicky Shih, Nikhilesh Korgaonkar, Ebondo Mpinga, Quincy K. Tran, Rahul Kashyap   +5 more
doaj   +1 more source